CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?
CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
| Ticker |
CVS
|
| CIK | 0000064803 |
| SIC | 5912 |
| Sector | Retail Trade |
| Industry Category | Retail |
| Industry Group | Retail – Drug & Proprietary Stores |
| Address | ONE CVS DR., WOONSOCKET, RI, 02895 |
| Website | cvshealth.com |
| Phone | 4017651500 |
| CEO | Karen S. Lynch |
| Employees | 300,000 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks. Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains. Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?Here is how Agenus (AGEN) and CVS Health (CVS) have performed compared to their sector so far this year. ABT to Report Q2 Earnings: CGM and Cardiac Devices in FocusAbbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments. Jefferies Maintains ‘Buy’ Rating on CVS Health Corporation (CVS); Raises PTBillionaire Kerr Neilson has bought over $290,715 worth of shares in CVS Health Corporation (NYSE:CVS), representing 0.02% of his stock portfolio, securing the company a spot in Billionaire Kerr Neilson’s 10 Stock Picks with Huge Upside Potential. On June 30, 2025, Jefferies increased its price target on CVS Health Corporation (NYSE:CVS) from $74 to $80. […] |